October 11, 2012
Pricey Soliris Performs in Another Rare Disease
Alexion’s ($ALXN) Soliris is arguably the most expensive drug in the world. The rare-disease therapy fights two life-threatening diseases–and it costs up to $400,000 per year, depending upon the patient. And if the company has its way, the drug may be targeted at another group of patients…Patients with NMO are progressively disabled by each attack. […]
Tags: Alexion, FiercePharma, Sean J. Pittock, Soliris